Determina la utilidad de la PET CT en el seguimiento postratamiento y detección de recurrencia en sarcomas óseos y de tejidos blandos en el Hospital Edgardo Rebagliati Martins–EsSalud, 2015-2018. Hasta el momento no hay estudios realizados en nuestro país en relación al tema, por lo que su realización, podría ser considerada de gran valor en proveernos de información necesaria, en la evaluación de los pacientes oncológicos, que anualmente sigue en aumento. La información y conclusiones que se realicen a partir de este estudio, por ser el Hospital Edgardo Rebagliati establecimiento de referencia nacional, pueda contribuir a mejorar la salud de la población que padezca de patología oncológica y ser extrapolados a la población nacional, toda vez que estudios de seguimiento de tratamientos oncológicos y control de recurrencias, son necesarios para poder valorar el tiempo de ...

They are registered 520 oncology patients in the National Hospital of South East EsSALUD (HNSE) of Cusco-Perú at 3340 m. above sea level in the period of 1996 to 1999, occupying the 4th place the hematologic neoplasia, after the mamma cancer, cervix cancer and prostatic cancer. They were reviewed 44 clinic histories of patients with malignant proliferative disease of leukocyte, 14 of which are death, we have 8 patients with acute leukaemia, 2 with multiple mieloma, a patient with histiocitosis and 33 patients with malignant lymphoma, of which 30 them fulfilled with criteria of inclusion expressed in this research. The results were the following: 1. The limphoproliferative syndrome occupy the 4th place in the HNSE, the prevalence of these neoplasia is of 9.24 for 100,000 inhabitants.  2. Female are the most affected (60%) 3. It presents with most frequency in elder of 60 y...

They are registered 520 oncology patients in the National Hospital of South East EsSALUD (HNSE) of Cusco-Perú at 3340 m. above sea level in the period of 1996 to 1999, occupying the 4th place the hematologic neoplasia, after the mamma cancer, cervix cancer and prostatic cancer. They were reviewed 44 clinic histories of patients with malignant proliferative disease of leukocyte, 14 of which are death, we have 8 patients with acute leukaemia, 2 with multiple mieloma, a patient with histiocitosis and 33 patients with malignant lymphoma, of which 30 them fulfilled with criteria of inclusion expressed in this research. The results were the following: 1. The limphoproliferative syndrome occupy the 4th place in the HNSE, the prevalence of these neoplasia is of 9.24 for 100,000 inhabitants.  2. Female are the most affected (60%) 3. It presents with most frequency in elder of 60 y...